Perineologic

What Perineologic does

Perineologic is a privately held medical device company headquartered at 183 N. Centre Street, Cumberland, Maryland, that develops and commercializes the PrecisionPoint Transperineal Access System (PPTAS), the first FDA-cleared device enabling freehand transperineal biopsy of the prostate. Founded in 2014 by practicing urologist Dr. Matthew J. Allaway—who has more than twenty years of clinical experience at Urology Associates in Cumberland and was himself motivated by safety shortcomings in the transrectal biopsy approach—the company spent roughly four years developing the device before receiving FDA clearance. PrecisionPoint uses a patented clamping mechanism compatible with existing BK ultrasound platforms and cylindrical transrectal probes to allow biopsy access through the perineum rather than the rectum, eliminating bowel prep and antibiotic prophylaxis, reducing infection risk to near zero versus the 2–6% rate associated with the transrectal route, and enabling strategic sampling of the anterior prostate where approximately 94% of post-transrectal missed cancers have been documented. The procedure takes 15–20 minutes under local or twilight anesthesia and requires only two skin punctures for comprehensive sampling.

The company’s commercial model is direct enterprise field sales of the FDA-cleared Class II hardware to urology practices, hospitals, and ambulatory surgery centers, complemented by provider training and certification through a documented provider enrollment program and a patient-facing 'Find a PrecisionPoint Provider' locator that pulls demand toward trained sites. As of mid-2022, approximately 500 U.S. urologists had been trained to use the device, with the system in use across 13+ countries and roughly 70% transperineal biopsy penetration reported in the United Kingdom within two years. Perineologic operates with 1–10 employees, has not disclosed institutional funding, and is led by a commercial team drawn from Boston Scientific, Medtronic, Intuitive Surgical, and Smith+Nephew, with ten issued U.S. patents and five pending applications protecting both the current device and a pipeline of potential future products.

Name

Perineologic

Legal name

Perineologic

Website

https://perineologic.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Perineologic is a privately held medical device company that developed the FDA-cleared PrecisionPoint Transperineal Access System for freehand transperineal prostate biopsy, selling directly to urology practices and hospitals across 13+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Cumberland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. PrecisionPoint Device Sales: Perineologic generates revenue through the sale of its PrecisionPoint Transperineal Access System medical devices to urology practices, hospitals, and healthcare systems. As a Class II medical device requiring FDA clearance, the product is sold directly to trained providers who perform prostate biopsies using the system.
2. Provider Training and Certification: The company likely generates revenue through training and certification programs for urologists adopting the PrecisionPoint technique, though specific pricing for training services is not publicly disclosed.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Perineologic develops, manufactures, and sells the PrecisionPoint Transperineal Access System (PPTAS), an FDA-cleared Class II medical device that enables urologists to perform freehand transperineal prostate biopsies through the perineum rather than the rectum. The system includes a patented clamping mechanism compatible with existing BK ultrasound platforms and cylindrical transducer probes, eliminating the need for bowel prep or antibiotics and reducing infection risk to nearly zero.

Product overview

Perineologic® is an innovative medical device company focused on developing and delivering technology to improve the safety, precision, and efficiency of healthcare options primarily in the field of urology. The company's core product is the PrecisionPoint® Transperineal Access System (PPTAS), which is the first FDA-cleared device enabling free-handed transperineal biopsy of the prostate. This system revolutionizes prostate biopsy methodology by allowing access through the perineum rather than the rectum, eliminating infection risks and enabling more comprehensive cancer detection. The PPTAS works in conjunction with existing ultrasound platforms (specifically BK ultrasound systems) and enables urologists to perform safer, more accurate prostate biopsies under local anesthesia.

Differentiator

Problem solved

Functional benefit

Brands

• PrecisionPoint: The PrecisionPoint Transperineal Access System (PPTAS) - the first FDA cleared device allowing free-handed transperineal biopsy of the prostate. The device enables urologists to perform prostate biopsies through the perineum, avoiding the rectum entirely.

Products and services

• PrecisionPoint® Transperineal Access System (PPTAS) FDA-cleared Class II medical device that enables free-handed transperineal biopsy of the prostate through the perineum, avoiding the rectum entirely. The system eliminates the need for bowel prep and antibiotics, reduces infection risk to nearly 0%, and allows comprehensive sampling of all prostate zones including the anterior region. The procedure takes 15-20 minutes and can be performed under local or twilight anesthesia. Designed for urologists performing prostate biopsies.

Quantifiable outcome

• 94% of missed cancers after transrectal biopsies were located in the anterior region of the prostate, which PrecisionPoint can specifically target
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• BK Medical (Analogic Corporation)coreTechnology or IntegrationPerineologic's PrecisionPoint system is designed to be compatible with BK ultrasound platforms and cylindrical transrectal ultrasound transducer probes (BK #8658 or equivalent). This integration allows urologists to use their existing BK ultrasound equipment with the PrecisionPoint device, reducing adoption barriers for practices already equipped with BK systems.
• Urology Associates (Cumberland, MD)coreStrategic or Co-development PartnerDr. Matthew Allaway's urology practice served as the development and testing site for the PrecisionPoint technology. The practice, a 13,000-square-foot modern medical facility including clinical and research space and the Ambulatory Urologic Surgery Center, represents the foundational partnership where the technology was clinically developed over four years of development.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Boston Scientific: Major medtech incumbent with a deep Urology/Pelvic Health portfolio including biopsy, ablation, and prostate diagnostics. Comparable because it is the dominant force in urology devices Perineologic sells into, and former Perineologic executives (Brasington, Tanksley, Tourtellot) all came from Boston Scientific roles.
• Cook Medical: Long-established urology device manufacturer offering prostate biopsy needles, access devices, and procedure kits. Comparable because it competes for the same urology practice purchasing budgets and offers overlapping transrectal/transperineal biopsy supplies.
• GE HealthCare (BK Medical): Owns BK Medical, whose ultrasound platforms and TRUS transducers are explicitly compatible with PrecisionPoint. Comparable as both a key integration partner and a potential broader competitor if it expands into procedure-specific access devices.
• Philips (Invivo): Through Invivo, Philips provides MRI/ultrasound fusion-guided prostate biopsy solutions. Comparable as an alternative diagnostic biopsy workflow competing for urology department capital budgets and procedure referrals.
• Intuitive Surgical: Dominant robotic surgery platform (da Vinci) used after prostate cancer diagnosis, often in conjunction with PrecisionPoint biopsies. Comparable because it shares the same urology ecosystem and a former Perineologic SVP previously held a Director, Key Accounts role at Intuitive.
• Medtronic: Diversified medtech with urology and pelvic health offerings and a strong sales infrastructure into hospitals and ambulatory surgery centers. Comparable as a potential competitor with resources to enter transperineal access and a previous employer of Perineologic's SVP of Sales.
• Hologic: Women's health and diagnostics leader that also serves urology through prostate biopsy and related diagnostics. Comparable because it competes for hospital/urology group purchasing decisions and has biopsy device capabilities.
• Coloplast: Established urology and continence care company with prostate surgery and biopsy adjacencies. Comparable as a broader urology incumbent targeting the same clinical customers and could expand into transperineal access devices.

Direct peers

• AngioDynamics: Medical device company with a dedicated prostate health business (NanoKnife, biopsy, and ablation technologies). Comparable because it sells directly to urology practices for prostate biopsy and focal therapy procedures, overlapping Perineologic's call point.

Emerging players

• Biobot Surgical: Developer of robotic-assisted prostate biopsy and focal therapy devices (e.g., iSR'obot Mona Lisa). Comparable as a niche emerging competitor in the same transperineal biopsy category that PrecisionPoint addresses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/pnlogic
• Facebookfacebook.com/perineologic
• LinkedInlinkedin.com/company/perineologic
• Instagraminstagram.com/pnlogic

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Perineologic